ACT-EU (Accelerating Clinical Trials in the EU) is a Multi-stakeholders Platform Advisory Group, in which our network is contributing to with the definition of the ten Priority Actions (PAs) to drive the transformation of Clinical Research in Europe.
The TEDDY Network is committed to sharing its experience and strategic insights and, as part of our ongoing efforts, we are pleased to inform you about the upcoming Accelerating Clinical Trials (ACT) in the EU workshop, organised within the ACT EU Priority Action on the Modernization of Good Clinical Practice. Recognizing the crucial role of the International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH) Guideline E6 (E6) as a global standard for Good Clinical Practice, this workshop will focus on the updates introduced in ICH E6 R3, in particular on the principles and Annex 1, which have a direct impact on accelerating clinical trials in the EU. The event will take place on 19-20 February 2025 and is of significant importance to professionals in the clinical research field.
The goal of the event is to provide a detailed overview of the new guidelines and their practical implications, offering a valuable opportunity for discussion and knowledge exchange among all stakeholders. Your participation will be an excellent chance to delve into critical topics, address current challenges, and learn from best practices shared during the workshop.
We invite you to register and actively engage in this important event.
To participate, register by filling out the EU survey by 10 December 2024.
#RareDiseases #PediatricResearch #CVBF #ACT-EU #CinicalResearch #ClinicalTrials
